HROW
Harrow Health, Inc.
HROW lost money over the past year, so it has no meaningful PE right now. Analysts expect earnings to recover and profitability to improve, though they disagree widely on how much.
HROW Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Weak | |
| Weak |
HROW's revenue is currently strong, but its profitability, cash flow and balance sheet are under pressure.
HROW PE Valuation
HROW has no meaningful PE right now: it lost money over the past year. If it returns to profit as analysts expect, today's price would be 25x next year's earnings.
HROW Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect HROW to return to profit, with revenue growing. However, they disagree widely on these estimates.
HROW Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.13 | — |
| Q3 2026 | -$0.75 | -$0.60 |
| Q2 2026 | -$0.97 | -$0.67 |
| Q1 2026 | -$0.38 | +$0.23 |
| Q4 2025 | -$0.14 | +$0.35 |
| Q3 2025 | -$0.15 | +$0.79 |
| Q2 2025 | -$0.30 | +$0.65 |
| Q1 2025 | -$0.61 | +$0.30 |
| Q4 2024 | -$0.49 | +$0.26 |
HROW lost $0.75 per share over the past year, a bigger loss than the year before.
HROW Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $99.3M | +39% |
| Q2 2026 | $70.7M | +11% |
| Q1 2026 | $44.2M | -7.6% |
| Q4 2025 | $89.1M | +33% |
| Q3 2025 | $71.6M | +45% |
| Q2 2025 | $63.7M | +30% |
| Q1 2025 | $47.8M | +38% |
| Q4 2024 | $66.8M | +84% |
HROW's revenue is growing: $99M last quarter, up 39% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 12% | -9 points |
| Q2 2026 | -16% | -34 points |
| Q1 2026 | -50% | -27 points |
| Q4 2025 | 18% | -1.8 points |
| Q3 2025 | 21% | +18 points |
| Q2 2025 | 18% | +15 points |
| Q1 2025 | -23% | -3.4 points |
| Q4 2024 | 19% | +33 points |
HROW's operating margin was 12% last quarter, down 9 points from the same quarter a year ago.
HROW Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$9M | -155% |
| Q2 2026 | -$10.2M | -$9.3M |
| Q1 2026 | -$9.2M | -147% |
| Q4 2025 | $8.1M | +$26.4M |
| Q3 2025 | $16.4M | +598% |
| Q2 2025 | -$969K | +$2.1M |
| Q1 2025 | $19.5M | +$24.2M |
| Q4 2024 | -$18.3M | -316% |
HROW's free cash flow was −$20M over the past year, against $17M the year before.
HROW Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.2% | +1.2M shares |
| 1 year | -0.9% | -341K shares |
| 3 years | +12% | +4.3M shares |
| 5 years | +42% | +11.4M shares |
| Available history | +46% | +12.1M shares |
HROW has 39M diluted shares, down 0.9% from a year ago.
HROW Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 9.7x | High |
| Q4 2025 | 5.5x | High |
| Q3 2025 | 9.3x | High |
| Q2 2025 | 12.2x | High |
| Q1 2025 | 29.7x | High |
| Q4 2024 | 20.2x | High |
| Q4 2023 | 88.0x | High |
| Q3 2023 | 37.2x | High |
HROW's net debt is about 9.7 years of its operating earnings (EBITDA), down from more than 20 years a year ago.
HROW Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.2 | Neutral |
| Stochastic | 9.8 | Oversold |
HROW's weekly RSI is 38 (neutral) and its Stochastic is 10 (oversold).
HROW PE vs Healthcare Sector
| Metric | HROW | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HROW has no meaningful PE right now: it lost money over the past year.
HROW Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.0 | 2.4% below |
| 20 week MA | $35.3 | 20% below |
| 50 week MA | $39.0 | 27% below |
| 100 week MA | $36.1 | 21% below |
| 200 week MA | $28.8 | 1.6% below |
HROW is in a downtrend: it's below all five of its weekly moving averages, and 1.6% below its 200-week average.
HROW Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $7.88 | $5.78 | -27% |
| 2021 | $5.78 | $9.20 | +59% |
| 2022 | $9.20 | $14.2 | +54% |
| 2023 | $14.2 | $11.2 | -21% |
| 2024 | $11.2 | $33.5 | +199% |
| 2025 | $33.5 | $50.1 | +50% |
| 2026 YTD | $50.1 | $28.3 | -44% |
HROW is down 44% so far in 2026, after finishing higher in four of the previous six years.